IP Library Granted Patent US 11,844,847
Granted Patent B2
US 11,844,847 · App. 17/265,945 · Granted Dec 19, 2023

Sulfur-containing polymerizable monomer and use thereof

Inventors: Hideo Matsumura (Tokyo, JP); Sayaka Miyamori (Moriyama, JP); Takashi Yamamoto (Moriyama, JP); Kazuhiko Yoshinaga (Moriyama, JP); Shigeru Mio (Chiba, JP); Shinji Kiyono (Kimitsu, JP); Hina Suzuki (Chiba, JP)
Assignees: SUN MEDICAL CO., LTD.; MITSUI CHEMICALS, INC.
A61K6/30A61K6/62A61K6/76C07D233/86C07D251/46C09J133/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,844,847
App. No.
17/265,945
Granted
Dec 19, 2023
Kind
B2
Abstract

A compound (A) is represented by the formula (1): wherein R 1 is a hydrogen atom or an alkali metal atom, R 2 is a hydrogen atom or an alkali metal atom, R 3 is a hydrogen atom or a methyl group, Z is a divalent or trivalent organic group, and the lines consisting of a solid line and a broken line bonded to Z represent a single bond or a double bond.

Claims (21)

1. A compound (A) represented by the formula (1):

wherein

R 1 is a hydrogen atom or an alkali metal atom,

R 2 is a hydrogen atom or an alkali metal atom,

R 3 is a hydrogen atom or a methyl group,

Z is a divalent or trivalent organic group, and the lines consisting of a solid line and a broken line bonded to Z represent a single bond or a double bond,

provided that when R 1 and R 2 are a hydrogen atom, and R 3 is a methyl group, Z is not a trivalent organic group including 1,4-phenylene group,

the compound (A) is not a compound represented by following formula:

the divalent or trivalent organic group Z in the formula (1) includes one or more groups selected from divalent groups represented by formula (Z1), ether bonds, 1,4-phenylene groups, 1,4-cyclohexylene groups and divalent linear saturated hydrocarbon groups,

wherein Y 1 and Y 2 are each independently an oxygen atom, a divalent group represented by —CH 2 — or a divalent group represented by —NH—, and Y 3 is an oxygen atom or a sulfur atom.

2. The compound (A) according to claim 1 , wherein the molecular weight is 200 to 600.

3. The compound (A) according to claim 1 , wherein the topological polar surface area (tPSA) is not less than 50.00 Å 2 .

4. The compound (A) according to claim 3 , wherein the C log P value is not less than −5.000.

5. The compound (A) according to claim 1 , wherein the divalent or trivalent organic group Z in the formula (1) is a C6-C20 linear saturated hydrocarbon group or a C6-C20 group having —O—C(═O)—CH 2 —.

6. A cured product obtained by curing an adhesive composition comprising a compound (A) represented by the formula (1) to a metal including a noble metal, a tooth substance or a ceramic:

wherein R 1 is a hydrogen atom or an alkali metal atom,

R 2 is a hydrogen atom or an alkali metal atom,

R 3 is a hydrogen atom or a methyl group,

Z is a divalent or trivalent organic group, and the lines consisting of a solid line and a broken line bonded to Z represent a single bond or a double bond.

7. The compound (A) according to claim 1 , wherein —C(═O)O— in the formula (1) is bonded to a CH 2 group in Z.

8. The compound (A) according to claim 1 , wherein the divalent or trivalent organic group Z in the formula (1) includes one or more groups selected from divalent groups represented by formula (Z1), ether bonds, 1,4-cyclohexylene groups and divalent linear saturated hydrocarbon groups.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2021
From: MATSUMURA, HIDEO; MIYAMORI, SAYAKA; YAMAMOTO, TAKASHI; YOSHINAGA, KAZUHIKO; MIO, SHIGERU; KIYONO, SHINJI; SUZUKI, HINA
To: SUN MEDICAL CO., LTD.; MITSUI CHEMICALS, INC.
Reel/Frame 057327/0714 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: MATSUMURA, HIDEO; MIYAMORI, SAYAKA; YAMAMOTO, TAKASHI; YOSHINAGA, KAZUHIKO; MIO, SHIGERU; KIYONO, SHINJI; SUZUKI, HINA
To: SUN MEDICAL CO., LTD.; MITSUI CHEMICALS, INC.
Reel/Frame 055149/0425 →
Priority Claims (1)
JP 2018-150309 · Aug 9, 2018 · national
Continuity (1)
Related Publication 20210298997A1 · Sep 30, 2021